Line 10: |
Line 10: |
| !'''Date of Last Editor Review''' | | !'''Date of Last Editor Review''' |
| !'''Notes''' | | !'''Notes''' |
− | |-|[[BRST5:Usual_ductal_hyperplasia|Usual ductal hyperplasia]] | + | |- |
| + | |
| + | |[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Angiocentric_glioma|Angiocentric glioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered ]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma ]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Chordoid_glioma|Chordoid glioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Ganglioglioma|Ganglioglioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Gangliocytoma|Gangliocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Central_neurocytoma|Central neurocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive ]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Spinal_ependymoma|Spinal ependymoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]] |
| |Disease | | |Disease |
| | | | | |
Line 21: |
Line 452: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Columnar_cell_lesions,_including_flat_epithelial_atypia_|Columnar cell lesions, including flat epithelial atypia ]] | + | |[[CNS5:Subependymoma|Subependymoma]] |
| |Disease | | |Disease |
| | | | | |
Line 32: |
Line 463: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Atypical_ductal_hyperplasia|Atypical ductal hyperplasia]] | + | |[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]] |
| |Disease | | |Disease |
| | | | | |
Line 43: |
Line 474: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Sclerosing_adenosis|Sclerosing adenosis]] | + | |[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]] |
| |Disease | | |Disease |
| | | | | |
Line 54: |
Line 485: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Apocrine_adenosis_and_adenoma|Apocrine adenosis and adenoma]] | + | |[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]] |
| |Disease | | |Disease |
| | | | | |
Line 65: |
Line 496: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Microglandular_adenosis_|Microglandular adenosis ]] | + | |[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]] |
| |Disease | | |Disease |
| | | | | |
Line 76: |
Line 507: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Radial_scar_/_complex_sclerosing_lesion_|Radial scar / complex sclerosing lesion ]] | + | |[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]] |
| |Disease | | |Disease |
| | | | | |
Line 87: |
Line 518: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Tubular_adenoma_|Tubular adenoma ]] | + | |[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]] |
| |Disease | | |Disease |
| | | | | |
Line 98: |
Line 529: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Lactating_adenoma_|Lactating adenoma ]] | + | |[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]] |
| |Disease | | |Disease |
| | | | | |
Line 109: |
Line 540: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Ductal_adenoma|Ductal adenoma]] | + | |[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]] |
| |Disease | | |Disease |
| | | | | |
Line 120: |
Line 551: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Pleomorphic_adenoma|Pleomorphic adenoma]] | + | |[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]] |
| |Disease | | |Disease |
| | | | | |
Line 131: |
Line 562: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]] | + | |[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]] |
| |Disease | | |Disease |
| | | | | |
Line 142: |
Line 573: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Malignant_adenomyoepithelioma|Malignant adenomyoepithelioma]] | + | |[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]] |
| |Disease | | |Disease |
| | | | | |
Line 153: |
Line 584: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Intraductal_papilloma|Intraductal papilloma]] | + | |[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]] |
| |Disease | | |Disease |
| | | | | |
Line 164: |
Line 595: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Papillary_ductal_carcinoma_in_situ|Papillary ductal carcinoma in situ]] | + | |[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]] |
| |Disease | | |Disease |
| | | | | |
Line 175: |
Line 606: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Encapsulated_papillary_carcinoma|Encapsulated papillary carcinoma]] | + | |[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]] |
| |Disease | | |Disease |
| | | | | |
Line 186: |
Line 617: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Solid_papillary_carcinoma_(in_situ_and_invasive)|Solid papillary carcinoma (in situ and invasive)]] | + | |[[CNS5:Pineocytoma|Pineocytoma]] |
| |Disease | | |Disease |
| | | | | |
Line 197: |
Line 628: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Invasive_papillary_carcinoma|Invasive papillary carcinoma]] | + | |[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]] |
| |Disease | | |Disease |
| | | | | |
Line 208: |
Line 639: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Atypical_lobular_hyperplasia_|Atypical lobular hyperplasia ]] | + | |[[CNS5:Pineoblastoma|Pineoblastoma]] |
| |Disease | | |Disease |
| | | | | |
Line 219: |
Line 650: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Lobular_carcinoma_in_situ|Lobular carcinoma in situ]] | + | |[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]] |
| |Disease | | |Disease |
| | | | | |
Line 230: |
Line 661: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Ductal_carcinoma_in_situ_|Ductal carcinoma in situ ]] | + | |[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]] |
| |Disease | | |Disease |
| | | | | |
Line 241: |
Line 672: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Invasive_breast_carcinoma:_General_overview|Invasive breast carcinoma: General overview]] | + | |[[CNS5:Schwannoma|Schwannoma]] |
| |Disease | | |Disease |
| | | | | |
Line 252: |
Line 683: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Invasive_breast_carcinoma_of_no_special_type|Invasive breast carcinoma of no special type]] | + | |[[CNS5:Neurofibroma|Neurofibroma]] |
| |Disease | | |Disease |
| | | | | |
Line 263: |
Line 694: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Microinvasive_carcinoma|Microinvasive carcinoma]] | + | |[[CNS5:Perineurioma|Perineurioma]] |
| |Disease | | |Disease |
| | | | | |
Line 274: |
Line 705: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Invasive_lobular_carcinoma_|Invasive lobular carcinoma ]] | + | |[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]] |
| |Disease | | |Disease |
| | | | | |
Line 285: |
Line 716: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Tubular_carcinoma|Tubular carcinoma]] | + | |[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]] |
| |Disease | | |Disease |
| | | | | |
Line 296: |
Line 727: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Cribriform_carcinoma|Cribriform carcinoma]] | + | |[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] |
| |Disease | | |Disease |
| | | | | |
Line 307: |
Line 738: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Mucinous_carcinoma|Mucinous carcinoma]] | + | |[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]] |
| |Disease | | |Disease |
| | | | | |
Line 318: |
Line 749: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Mucinous_cystadenocarcinoma|Mucinous cystadenocarcinoma]] | + | |[[CNS5:Meningioma|Meningioma]] |
| |Disease | | |Disease |
| | | | | |
Line 329: |
Line 760: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Invasive_micropapillary_carcinoma|Invasive micropapillary carcinoma]] | + | |[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]] |
| |Disease | | |Disease |
| | | | | |
Line 340: |
Line 771: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Carcinoma_with_apocrine_differentiation|Carcinoma with apocrine differentiation]] | + | |[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]] |
| |Disease | | |Disease |
| | | | | |
Line 351: |
Line 782: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Metaplastic_carcinoma|Metaplastic carcinoma]] | + | |[[CNS5:Haemangioblastoma|Haemangioblastoma]] |
| |Disease | | |Disease |
| | | | | |
Line 362: |
Line 793: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Acinic_cell_carcinoma|Acinic cell carcinoma]] | + | |[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]] |
| |Disease | | |Disease |
| | | | | |
Line 373: |
Line 804: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]] | + | |[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]] |
| |Disease | | |Disease |
| | | | | |
Line 384: |
Line 815: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Secretory_carcinoma_|Secretory carcinoma ]] | + | |[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] |
| |Disease | | |Disease |
| | | | | |
Line 395: |
Line 826: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]] | + | |[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]] |
| |Disease | | |Disease |
| | | | | |
Line 406: |
Line 837: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]] | + | |[[CNS5:Ewing_sarcoma|Ewing sarcoma]] |
| |Disease | | |Disease |
| | | | | |
Line 417: |
Line 848: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Tall_cell_carcinoma_with_reversed_polarity|Tall cell carcinoma with reversed polarity]] | + | |[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] |
| |Disease | | |Disease |
| | | | | |
Line 428: |
Line 859: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Neuroendocrine_tumour|Neuroendocrine tumour]] | + | |[[CNS5:Chondrosarcoma|Chondrosarcoma]] |
| |Disease | | |Disease |
| | | | | |
Line 439: |
Line 870: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Neuroendocrine_carcinoma|Neuroendocrine carcinoma]] | + | |[[CNS5:Chordoma|Chordoma]] |
| |Disease | | |Disease |
| | | | | |
Line 450: |
Line 881: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Hamartoma_|Hamartoma ]] | + | |[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]] |
| |Disease | | |Disease |
| | | | | |
Line 461: |
Line 892: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Fibroadenoma_|Fibroadenoma ]] | + | |[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]] |
| |Disease | | |Disease |
| | | | | |
Line 472: |
Line 903: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Phyllodes_tumour_|Phyllodes tumour ]] | + | |[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]] |
| |Disease | | |Disease |
| | | | | |
Line 483: |
Line 914: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Syringomatous_tumour_|Syringomatous tumour ]] | + | |[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]] |
| |Disease | | |Disease |
| | | | | |
Line 494: |
Line 925: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Nipple_adenoma_|Nipple adenoma ]] | + | |[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]] |
| |Disease | | |Disease |
| | | | | |
Line 505: |
Line 936: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Paget_disease_of_the_breast|Paget disease of the breast]] | + | |[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]] |
| |Disease | | |Disease |
| | | | | |
Line 516: |
Line 947: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Haemangioma|Haemangioma]] | + | |[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]] |
| |Disease | | |Disease |
| | | | | |
Line 527: |
Line 958: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Angiomatosis|Angiomatosis]] | + | |[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]] |
| |Disease | | |Disease |
| | | | | |
Line 538: |
Line 969: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Atypical_vascular_lesions_|Atypical vascular lesions ]] | + | |[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]] |
| |Disease | | |Disease |
| | | | | |
Line 549: |
Line 980: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Postradiation_angiosarcoma_of_the_breast|Postradiation angiosarcoma of the breast]] | + | |[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]] |
| |Disease | | |Disease |
| | | | | |
Line 560: |
Line 991: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Primary_angiosarcoma_of_the_breast|Primary angiosarcoma of the breast]] | + | |[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]] |
| |Disease | | |Disease |
| | | | | |
Line 571: |
Line 1,002: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Nodular_fasciitis|Nodular fasciitis]] | + | |[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] |
| |Disease | | |Disease |
| | | | | |
Line 582: |
Line 1,013: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Myofibroblastoma|Myofibroblastoma]] | + | |[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]] |
| |Disease | | |Disease |
| | | | | |
Line 593: |
Line 1,024: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Desmoid_fibromatosis_|Desmoid fibromatosis ]] | + | |[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]] |
| |Disease | | |Disease |
| | | | | |
Line 604: |
Line 1,035: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour ]] | + | |[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]] |
| |Disease | | |Disease |
| | | | | |
Line 615: |
Line 1,046: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Schwannoma_|Schwannoma ]] | + | |[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]] |
| |Disease | | |Disease |
| | | | | |
Line 626: |
Line 1,057: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Neurofibroma_|Neurofibroma ]] | + | |[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]] |
| |Disease | | |Disease |
| | | | | |
Line 637: |
Line 1,068: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Granular_cell_tumour|Granular cell tumour]] | + | |[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]] |
| |Disease | | |Disease |
| | | | | |
Line 648: |
Line 1,079: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Leiomyoma|Leiomyoma]] | + | |[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]] |
| |Disease | | |Disease |
| | | | | |
Line 659: |
Line 1,090: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Leiomyosarcoma_|Leiomyosarcoma ]] | + | |[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]] |
| |Disease | | |Disease |
| | | | | |
Line 670: |
Line 1,101: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Lipoma_|Lipoma ]] | + | |[[CNS5:Pituitary_blastoma|Pituitary blastoma]] |
| |Disease | | |Disease |
| | | | | |
Line 681: |
Line 1,112: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Angiolipoma_|Angiolipoma ]] | + | |[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]] |
| |Disease | | |Disease |
| | | | | |
Line 692: |
Line 1,123: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Liposarcoma_|Liposarcoma ]] | + | |[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]] |
| |Disease | | |Disease |
| | | | | |
Line 703: |
Line 1,134: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Pseudoangiomatous_stromal_hyperplasia|Pseudoangiomatous stromal hyperplasia]] | + | |[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] |
| |Disease | | |Disease |
| | | | | |
Line 714: |
Line 1,145: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]] | + | |[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] |
| |Disease | | |Disease |
| | | | | |
Line 725: |
Line 1,156: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Follicular_lymphoma_|Follicular lymphoma ]] | + | |[[CNS5:Schwannomatosis|Schwannomatosis]] |
| |Disease | | |Disease |
| | | | | |
Line 736: |
Line 1,167: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma ]] | + | |[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 747: |
Line 1,178: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Burkitt_lymphoma|Burkitt lymphoma]] | + | |[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]] |
| |Disease | | |Disease |
| | | | | |
Line 758: |
Line 1,189: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Breast_implant-associated_anaplastic_large_cell_lymphoma_|Breast implant-associated anaplastic large cell lymphoma ]] | + | |[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 769: |
Line 1,200: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Gynaecomastia|Gynaecomastia]] | + | |[[CNS5:Cowden_syndrome|Cowden syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 780: |
Line 1,211: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Carcinoma_in_situ|Carcinoma in situ]] | + | |[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 791: |
Line 1,222: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Invasive_carcinoma|Invasive carcinoma]] | + | |[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] |
| |Disease | | |Disease |
| | | | | |
Line 802: |
Line 1,233: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Metastases_to_the_breast|Metastases to the breast]] | + | |[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 813: |
Line 1,244: |
| | | | | |
| |- | | |- |
− | |[[BRST5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]] | + | |[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 824: |
Line 1,255: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Cowden_syndrome|Cowden syndrome]] | + | |[[CNS5:Carney_complex|Carney complex]] |
| |Disease | | |Disease |
| | | | | |
Line 835: |
Line 1,266: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | + | |[[CNS5:DICER1_syndrome|DICER1 syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 846: |
Line 1,277: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Li-Fraumeni_syndrome,_TP53-associated|Li-Fraumeni syndrome, TP53-associated]] | + | |[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] |
| |Disease | | |Disease |
| | | | | |
Line 857: |
Line 1,288: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Li-Fraumeni_syndrome,_CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]] | + | |[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 868: |
Line 1,299: |
| | | | | |
| |- | | |- |
− | |[[BRST5:CDH1-associated_breast_cancer|CDH1-associated breast cancer]] | + | |[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]] |
| |Disease | | |Disease |
| | | | | |
Line 879: |
Line 1,310: |
| | | | | |
| |- | | |- |
− | |[[BRST5:PALB2-associated_cancers|PALB2-associated cancers]] | + | |[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] |
| |Disease | | |Disease |
| | | | | |
Line 890: |
Line 1,321: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]] | + | |[[CNS5:Fanconi_anaemia|Fanconi anaemia]] |
| |Disease | | |Disease |
| | | | | |
Line 901: |
Line 1,332: |
| | | | | |
| |- | | |- |
− | |[[BRST5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | + | |[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]] |
| |Disease | | |Disease |
| | | | | |